ANGO logo

ANGO

AngioDynamics Inc.

$10.73
-$0.04(-0.37%)
42
Overall
60
Value
25
Tech
--
Quality
Market Cap
$437.63M
Volume
287.24K
52W Range
$5.83 - $13.50
Target Price
$19.00
Order:

Income Statement

MetricTrendChart
2016
May
2017
May
2018
May
2019
May
2020
May
2021
May
2022
May
2023
May
2024
May
2025
May
REVENUE
Total Revenue
$353.9M$349.6M$261.7M$270.6M$264.2M$291.0M$316.2M$338.8M$303.9M$292.5M
Total Revenue
$353.9M$269.8M$261.7M$270.6M$264.2M$291.0M$316.2M$338.8M$303.9M$292.5M
COST OF GOODS SOLD
Cost of Revenue
$-179.6M$-173.5M$-117.8M$114.6M$113.9M$134.2M$150.5M$164.5M$149.2M$134.8M
GROSS PROFIT
Gross Profit
$174.3M$143.9M$143.9M$156.0M$150.3M$156.8M$165.7M$174.2M$154.7M$157.7M
OPERATING EXPENSES
Operating Expenses
$-173.3M$-163.2M$-158.0M$165.4M$317.4M$192.1M$183.9M$225.4M$401.6M$197.7M
Research & Development
$25.1M$25.3M$24.3M$28.3M$29.7M$36.4M$30.7M$29.9M$31.5M$26.2M
Research Expense
$25.1M$25.3M$24.3M$28.3M$29.7M$36.4M$30.7M$29.9M$31.5M$26.2M
Selling, General & Administrative
$114.3M$110.2M$104.1M$111.7M$116.5M$117.2M$133.8M$144.3M$144.0M$145.2M
Selling & Marketing Expenses
$83.7M$78.8M$73.1M$76.8M$78.6M$81.3M$95.3M$104.2M$102.8M$103.1M
General & Administrative Expenses
$30.6M$31.4M$31.0M$34.9M$37.9M$35.9M$38.5M$40.0M$41.2M$42.1M
Salaries & Wages
$-3.2M$-6.2M$-7.9M$-2.1M$-1.7M$-2.0M$-2.5M------
Depreciation & Amortization
$18.0M$17.3M$13.9M$17.1M$18.1M$18.1M$19.5M$18.8M$13.0M$10.3M
Depreciation & Amortization
$18.0M$17.3M$13.9M$17.1M$18.1M$18.1M$19.5M$18.8M$13.0M$10.3M
Amortization
$18.0M$17.3M$13.9M$17.1M$18.1M$18.1M$19.5M$18.8M$13.0M$10.3M
Other Operating Expenses
$16.0M$10.4M$15.7M$-8.4M$5.5M$-20.3M$2.8M------
OPERATING INCOME
Operating income
$1.0M$13.0M$-14.2M$-9.4M$-167.1M$-35.3M$-28.5M$-51.2M$-192.4M$-40.0M
EBITDA
$28.2M$37.5M$9.0M$16.3M$-143.4M$-9.3M$88.0K$-20.9M$-165.5M$-9.2M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$3.4M$2.8M$3.1M$5.1M$907.0K$861.0K$688.0K$2.7M$-1.6M$-978.0K
Intinc
$11.0K------------------
Net Non-Operating Interest Income/Expense
$-3.4M$-2.8M$-3.1M$-5.1M$-907.0K$-861.0K$-688.0K$-2.7M$1.6M$978.0K
Other Income/Expense
$886.0K$-9.6M$17.3M$14.9M$130.0K$-92.0K$-11.0M$554.0K$-53.7M$-4.9M
Other Special Charges
$-886.0K$9.6M$-31.0K$-14.9M$-130.0K$92.0K$-790.0K$-554.0K$-817.0K$4.9M
SPECIAL ITEMS
Restructring And Mn A Income
--$-1.3M$-4.7M$288.0K$26.0K----------
Special Income Charges
--$1.3M$4.7M$-288.0K$-158.6M----$-14.5M$-159.5M--
Impairment of Capital Assets
--------$158.6M----$14.5M$159.5M--
PRE-TAX INCOME
EBIT
$132.0K$12.7M$-14.2M$-9.6M$-167.2M$-35.2M$-29.3M$-51.7M$-193.3M$-35.0M
Pre-Tax Income
$-3.3M$9.8M$-17.3M$-14.7M$-168.1M$-36.1M$-29.9M$-54.4M$-191.6M$-34.0M
INCOME TAX
Tax Provision
$40.3M$4.8M$-11.0M$-3.6M$-1.3M$-4.5M$-3.4M$-2.0M$-7.3M$-39.0K
NET INCOME
Net Income
$-46.8M$14.9M$-23.5M$61.3M$-166.8M$-31.5M$-26.5M$-52.4M$-184.3M$-34.0M
Net Income (Continuing Operations)
$-46.8M$14.9M$-23.5M$61.3M$-166.8M$-31.5M$-26.5M$-52.4M$-184.3M$-34.0M
Net Income (Discontinued Operations)
$-46.8M$14.9M$-23.5M$61.3M$-166.8M$-31.5M$-26.5M$-52.4M$-184.3M$-34.0M
Net Income (Common Stockholders)
$-46.8M$14.9M$-23.5M$-9.2M$-166.8M$-31.5M$-26.5M$-52.4M$-184.3M$-34.0M
Normalized Income
------------------$-34.1M
TOTALS
Total Expenses
$-352.9M$-336.7M$-275.8M$280.0M$431.3M$326.3M$334.4M$389.9M$550.8M$332.5M
SHARE & EPS DATA
Average Shares Outstanding
$36.2M$36.6M$37.1M$37.5M$38.0M$38.3M$39.0M$39.5M$40.2M$40.9M
Average Shares Outstanding (Diluted)
$36.2M$37.0M$37.1M$37.5M$38.0M$38.3M$39.0M$39.5M$40.2M$40.9M
Shares Outstanding
$36.4M$36.6M$36.9M$37.3M$37.9M$38.4M$39.0M$39.7M$40.3M$40.6M
Basic EPS
$-1.21$0.14$0.44$1.63$-4.39$-0.82$-0.68$-1.33$-4.59$-0.83
Basic EPS (Continuing Operations)
----$-0.17$-0.30$-4.39$-0.82$-0.68$-1.33$-4.59$-0.83
Diluted EPS
$-1.21$0.14$0.44$1.63$-4.39$-0.82$-0.68$-1.33$-4.59$-0.83
Diluted EPS (Continuing Operations)
----$-0.17$-0.30$-4.39$-0.82$-0.68$-1.33$-4.59$-0.83
OTHER METRICS
Acquired In Process Rn D
--$9.8M----------------
Basic Discontinuous Operations
----$0.61$1.93------------
Diluted Discontinuous Operations
----$0.61$1.93------------
Earnings from equity interest
----------$-36.1M--------
Earnings From Equity Interest Net Of Tax
----------$-36.1M--------
Gain On Sale Of P P E
--------$-168.1M------$54.5M--
Net Income Discontinuous Operations
----$22.6M$72.5M------------
Other Gain Loss From Disposition Of Discontinued Operations
------$72.5M------------
Other Gand A
$30.6M$31.4M$31.0M$34.9M$37.9M$35.9M$38.5M$40.0M$41.2M$42.1M
Other Impairment Of Capital Assets
$-100.0K------------------
Realized Capital Gain
----$7.5M--------------
Rent And Landing Fees
$30.6M$31.4M$31.0M$2.5M------------
Selling Expense
$83.7M$78.8M$73.1M--------------
Restruct
--$-1.3M$-4.7M$288.0K$26.0K----------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2ANGO$10.73-0.4%287.24K
3
4
5
6

Get AngioDynamics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.